Inventor
ALITALO KARI
FI72 patents
⚠️ This page may combine multiple inventors who share the name “ALITALO KARI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LUDWIG INST CANCER RES
13 patentsUS6245530B1Jun 12, 2001
Receptor ligand
LUDWIG INST CANCER RES143 citations99
US6235713B1May 22, 2001
Vascular endothelial growth factor-D (VEGF-D) polypeptides
LUDWIG INST CANCER RES113 citations98
US5840693ANov 24, 1998
Vascular endothelial growth factor-B
LUDWIG INST CANCER RES156 citations98
US5607918AMar 4, 1997
Vascular endothelial growth factor-B and DNA coding therefor
LUDWIG INST CANCER RES239 citations98
US6689580B1Feb 10, 2004
Growth factor
LUDWIG INST CANCER RES59 citations96
US6331301B1Dec 18, 2001
Antibodies specific for vascular endothelial growth factor-B
LUDWIG INST CANCER RES58 citations95
US5928939AJul 27, 1999
Vascular endothelial growth factor-b and dna coding therefor
LUDWIG INST CANCER RES65 citations95
US7034105B2Apr 25, 2006
FLT4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
LUDWIG INST CANCER RES47 citations94
US6965010B2Nov 15, 2005
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
LUDWIG INST CANCER RES29 citations89
US6958147B1Oct 25, 2005
Use of VEGF-C to prevent restenosis
LUDWIG INST CANCER RES41 citations89
US6706687B1Mar 16, 2004
Platelet-derived growth factor D
LUDWIG INST CANCER RES41 citations89
US7125714B2Oct 24, 2006
Progenitor cell materials and methods
LUDWIG INST CANCER RES12 citations84
US6764820B2Jul 20, 2004
Screening for lymphatic disorders involving the FLT4 receptor tyrosine kinase (VEGFR-3)
LUDWIG INST CANCER RES11 citations69
VEGENICS LTD
13 patentsUS7423125B2Sep 9, 2008
Antibodies to VEGF-C
VEGENICS LTD39 citations96
US7410639B2Aug 12, 2008
Vascular endothelial growth factor D(VEGF-D) antibodies and methods of use
VEGENICS LTD25 citations95
US7785803B2Aug 31, 2010
Antibody diagnostic kits and methods of use
VEGENICS LTD14 citations92
US7422741B2Sep 9, 2008
VEGFR-3 fusion proteins
VEGENICS LTD19 citations92
US7855178B2Dec 21, 2010
Growth factor binding constructs materials and methods
VEGENICS LTD24 citations89
US7611711B2Nov 3, 2009
VEGFR-3 inhibitor materials and methods
VEGENICS LTD18 citations89
US7829091B2Nov 9, 2010
Therapy targeting FLT4 (VEGER-3) expressed in blood vessels
VEGENICS LTD10 citations84
US7727761B2Jun 1, 2010
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
VEGENICS LTD8 citations84
US7871798B2Jan 18, 2011
Mammalian cells that express VEGF-D polypeptides
VEGENICS LTD3 citations73
US7794756B1Sep 14, 2010
Methods of using antibodies to VEGF-C
VEGENICS LTD5 citations73
US7709270B2May 4, 2010
Vascular endothelial growth factor C (VEGF-C) protein diagnostic
VEGENICS LTD5 citations73
US7947472B2May 24, 2011
Expression vectors and cell lines expressing vascular endothelial growth factor D
VEGENICS LTD6 citations72
US7662932B2Feb 16, 2010
Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of use
VEGENICS LTD6 citations72
UNIV HELSINKI LICENSING
8 patentsUS6645933B1Nov 11, 2003
Receptor ligand VEGF-C
UNIV HELSINKI LICENSING117 citations99
US6403088B1Jun 11, 2002
Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3)
UNIV HELSINKI LICENSING152 citations99
US6221839B1Apr 24, 2001
FIt4 ligand and methods of use
UNIV HELSINKI LICENSING158 citations99
US6130071AOct 10, 2000
Vascular endothelial growth factor C (VEGF-C) ΔCys156 protein and gene, and uses thereof
UNIV HELSINKI LICENSING168 citations99
US6730658B1May 4, 2004
Stimulation of lymphatic growth with an FLT4 ligand
UNIV HELSINKI LICENSING74 citations98
US5776755AJul 7, 1998
FLT4, a receptor tyrosine kinase
UNIV HELSINKI LICENSING170 citations96
US7122654B2Oct 17, 2006
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
UNIV HELSINKI LICENSING33 citations95
US5877020AMar 2, 1999
Promoter for the receptor tyrosine kinase, Tie
UNIV HELSINKI LICENSING29 citations92
LICENTIA LTD
7 patentsUS6361946B1Mar 26, 2002
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
LICENTIA LTD149 citations97
US6818220B1Nov 16, 2004
Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof
LICENTIA LTD40 citations92
US7105481B2Sep 12, 2006
Method for stimulating connective tissue growth or wound healing
LICENTIA LTD16 citations91
US6824777B1Nov 30, 2004
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
LICENTIA LTD57 citations90
US6515105B1Feb 4, 2003
Neuropilin/growth factor complexes and uses thereof
LICENTIA LTD15 citations90
US8029984B2Oct 4, 2011
Materials and methods for colorectal cancer screening, diagnosis and therapy
LICENTIA LTD33 citations85
US7309604B2Dec 18, 2007
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
LICENTIA LTD7 citations73
ALITALO KARI
3 patentsUS8444957B2May 21, 2013
Methods of screening for neoplastic disease states
ALITALO KARI9 citations75
US8282931B2Oct 9, 2012
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
ALITALO KARI3 citations73
US8278098B2Oct 2, 2012
Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
ALITALO KARI5 citations72
VEGENICS PTY LTD
2 patentsVENGENICS LTD
1 patent(unassigned)
1 patentACHEN MARC G
1 patentVEGENIES LTD
1 patentShowing the top 50 of 72 patents by PatentIndex Score.